Literature DB >> 21031159

Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder.

Paul Daniel Arnold1, Frank P Macmaster, Gregory L Hanna, Margaret A Richter, Tricia Sicard, Eliza Burroughs, Yousha Mirza, Phillip C Easter, Michelle Rose, James L Kennedy, David R Rosenberg.   

Abstract

This pilot study was undertaken to determine if there was a significant association between specific glutamate system genes and regional volumes of interest implicated in the pathogenesis of obsessive-compulsive disorder (OCD). Volumetric magnetic resonance imaging (MRI) and genotyping of 7 polymorphisms in two genes, glutamate receptor, ionotropic, N-methyl-d-aspartate 2B (GRIN2B) and solute linked carrier, family 1, member 1 (SLC1A1) were conducted in 31 psychotropic-naïve pediatric OCD patients. The rs1805476 variant of GRIN2B was associated with left but not right orbital frontal cortex (OFC) (p=0.04) and right but not left anterior cingulate cortex (ACC) volume (p=0.02). The SLC1A1 rs3056 variant was associated with increased total (p=0.01), left (p=0.02) and right (p=0.02) thalamic volume. These results suggest that GRIN2B and SLC1A1 may be associated with regional volumetric alterations in OFC, ACC, and thalamus in children with OCD.

Entities:  

Year:  2009        PMID: 21031159      PMCID: PMC2964163          DOI: 10.1007/s11682-008-9050-3

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  64 in total

Review 1.  Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development.

Authors:  D R Rosenberg; G L Hanna
Journal:  Biol Psychiatry       Date:  2000-12-15       Impact factor: 13.382

2.  Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.

Authors:  A R Gilbert; G J Moore; M S Keshavan; L A Paulson; V Narula; F P Mac Master; C M Stewart; D R Rosenberg
Journal:  Arch Gen Psychiatry       Date:  2000-05

3.  Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder.

Authors:  D R Rosenberg; M S Keshavan; K M O'Hearn; E L Dick; W W Bagwell; A B Seymour; D M Montrose; J N Pierri; B Birmaher
Journal:  Arch Gen Psychiatry       Date:  1997-09

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy.

Authors:  D R Rosenberg; N R Benazon; A Gilbert; A Sullivan; G J Moore
Journal:  Biol Psychiatry       Date:  2000-08-15       Impact factor: 13.382

7.  A family study of obsessive-compulsive disorder.

Authors:  D L Pauls; J P Alsobrook; W Goodman; S Rasmussen; J F Leckman
Journal:  Am J Psychiatry       Date:  1995-01       Impact factor: 18.112

8.  Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder.

Authors:  Virginia L Willour; Yin Yao Shugart; Jack Samuels; Marco Grados; Bernadette Cullen; O Joseph Bienvenu; Ying Wang; Kung-Yee Liang; David Valle; Rudolf Hoehn-Saric; Mark Riddle; Gerald Nestadt
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

9.  Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Authors:  Ethan A Smith; Aileen Russell; Elisa Lorch; S Preeya Banerjee; Michelle Rose; Jennifer Ivey; Rashmi Bhandari; Gregory J Moore; David R Rosenberg
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

10.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

View more
  16 in total

Review 1.  Imaging-genetics applications in child psychiatry.

Authors:  Daniel S Pine; Monique Ernst; Ellen Leibenluft
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-04-09       Impact factor: 8.829

2.  Glutamate and the Treatment of Obsessive-Compulsive Disorder.

Authors:  Frank P Macmaster; David R Rosenberg
Journal:  Psychopharm Rev       Date:  2010-05-01

3.  A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.

Authors:  Chen Zhang; Zezhi Li; Zhiguo Wu; Jun Chen; Zuowei Wang; Daihui Peng; Wu Hong; Chengmei Yuan; Zhen Wang; Shunying Yu; Yifeng Xu; Lin Xu; Zeping Xiao; Yiru Fang
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

4.  Significant concordance of genetic variation that increases both the risk for obsessive-compulsive disorder and the volumes of the nucleus accumbens and putamen.

Authors:  Derrek P Hibar; Joshua W Cheung; Sarah E Medland; Mary S Mufford; Neda Jahanshad; Shareefa Dalvie; Raj Ramesar; Evelyn Stewart; Odile A van den Heuvel; David L Pauls; James A Knowles; Dan J Stein; Paul M Thompson
Journal:  Br J Psychiatry       Date:  2018-07       Impact factor: 9.319

5.  Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder.

Authors:  Pino Alonso; Mónica Gratacós; Cinto Segalàs; Georgia Escaramís; Eva Real; Mónica Bayés; Javier Labad; Clara López-Solà; Xavier Estivill; José M Menchón
Journal:  J Psychiatry Neurosci       Date:  2012-07       Impact factor: 6.186

Review 6.  The importance of the excitatory amino acid transporter 3 (EAAT3).

Authors:  Walden E Bjørn-Yoshimoto; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2016-05-24       Impact factor: 3.921

7.  Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

Authors:  Ke Wu; Gregory L Hanna; Philip Easter; James L Kennedy; David R Rosenberg; Paul D Arnold
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

8.  Orbital frontal cortex in treatment-naïve pediatric obsessive-compulsive disorder.

Authors:  Frank Macmaster; Anvi Vora; Phillip Easter; Carrie Rix; David Rosenberg
Journal:  Psychiatry Res       Date:  2010-01-13       Impact factor: 3.222

9.  NEUROBIOLOGICAL EVIDENCE SUPPORTING GLUTAMATE'S ROLE IN PEDIATRIC OBSESSIVE COMPULSIVE DISORDER.

Authors:  Frank P MacMaster; David R Rosenberg
Journal:  Child Adolesc Psychopharmacol News       Date:  2010-12

10.  Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms.

Authors:  Jun Cai; Wen Zhang; Zhenghui Yi; Weihong Lu; Zhiguo Wu; Jun Chen; Shunying Yu; Yiru Fang; Chen Zhang
Journal:  Psychopharmacology (Berl)       Date:  2013-05-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.